Bioregenx, Inc. (BRGX)

CIK 1593184 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Bioregenx, Inc..

Recent SEC filings

FiledFormAccession number
May 20, 202610-Q0001683168-26-004178
May 15, 2026NT 10-Q0001683168-26-003995
Apr 15, 202610-K0001683168-26-002975
Apr 1, 2026NT 10-K0001683168-26-002567
Nov 14, 202510-Q0001683168-25-008429
Aug 14, 202510-Q0001683168-25-006157
May 15, 202510-Q0001683168-25-003694
Apr 16, 202510-K/A0001683168-25-002623
Apr 15, 202510-K0001683168-25-002614
Apr 14, 20258-K0001683168-25-002550
Apr 1, 2025NT 10-K0001683168-25-002143
Jan 22, 20258-K0001683168-25-000484
Jan 2, 202530001683168-25-000016
Nov 14, 202410-Q0001683168-24-008044
Oct 11, 20248-K0001683168-24-007111
Oct 9, 202410-Q0001683168-24-007026
Oct 9, 20248-K/A0001683168-24-007019
Oct 9, 202410-Q/A0001683168-24-007021
Aug 12, 2024NT 10-Q0001683168-24-005468
Jul 23, 20248-K0001683168-24-004996
Jul 22, 2024SC 13D/A0001683168-24-004990
Jul 19, 2024SC 13D/A0001683168-24-004969
Jul 19, 2024SC 13D/A0001683168-24-004965
Jul 15, 20248-K0001683168-24-004835
Jun 11, 20248-K0001683168-24-004095